Catibig, Baby Girl .

HRN: 24-44-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/21/2024
01/28/2024
IV
20mg
Q36
PRETERM; PSNB
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: